Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

DRUG: Abiraterone acetate
DRUG: Prednisone

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor determined study is not required according to PFDA Circular 2013-004

Conditions

Janssen Pharmaceutica